Moreover, this regulatory form could also inhibit the efficacy of anti-PD-L1 immunotherapy for HCC by promoting the production of mTORC1-P70S6K-dependent PD-L1+ exosomes [188]. Here, CD274 is linked to hepatocellular carcinoma.